Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-10-19 Purchase | 2023-10-20 06:50 am | Protalix BioTherapeutics Inc. | PLX | Bashan Dror PRESIDENT AND CEO | 64,516 | $1.4025 | $90,484 | 132,516 (Direct) | View |
2022-04-11 Purchase | 2022-04-13 4:05 pm | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 68,000 | $1.5 | $102,000 | 1,153,458 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-01 Option Award | 2024-04-03 5:30 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror PRESIDENT AND CEO | 263,960 | $0 | 2,281,934 (Indirect) | View |
2023-08-15 Option Award | 2023-08-17 4:30 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 800,000 | $0 | 1,953,458 (Indirect) | View |
2022-09-07 Option Award | 2022-09-09 5:02 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 750,000 | $0 | 750,000 (Direct) | View |
2022-02-25 Option Award | 2022-02-28 5:01 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 637,531 | $0 | 1,085,458 (Indirect) | View |
2020-08-11 Option Award(A) | 2020-08-14 5:01 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 447,927 | $0 | 447,927 (Indirect) | View |
2020-08-11 Option Award | 2020-08-13 5:02 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 447,927 | $0 | 447,927 (Indirect) | View |